International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 144 | Views: 289

Case Studies | Medicine Science | United States of America | Volume 5 Issue 9, September 2016 | Rating: 6.6 / 10


Immune Reconstitution Graves Ophthalmopathy Induced by Haart Therapy in a Hypothyroid Male Patient

Yasir Ali MD, Hussein Elbadawi MD


Abstract: The objective is to report a rare case of a 41-year-old African American male who recently developed Graves Ophthalmopathy (GO) secondary to highly active antiretroviral therapy (HAART) induced Immune reconstitution inflammatory syndrome (IRIS). He is a known case of primary hypothyroidism treated with Levothyroxine since the age of 33 and found with AIDS at the age of 34 when HAART therapy was started. He then developed Graves disease (GD) with worsening GO when his CD4 T-cell counts improved. We treated our patient with Methimazole and followed him at regular intervals until his thyroid levels normalized. GD is an autoimmune condition caused by Thyroid stimulating immunoglobulins (TSI) leading to hyperthyroidism. Ocular problems are one of its manifestations, ranging from simple irritation to proptosis and even complete loss of vision. Patients on HAART may develop IRIS in 10-25 % of cases. Less than 1 % of IRIS cases present as GD and out of them only 25 % have reported GO which were of a milder version. Our case is the first case to show two coinciding points, one is development of a severe degree of GO and the other is the transition from hypothyroidism to Graves disease in a male patient treated with HAART.


Keywords: HIV, HAART therapy, Immune reconstitution inflammatory syndrome, Graves disease, Graves Ophthalmopathy, Hypothyroid male patient


Edition: Volume 5 Issue 9, September 2016,


Pages: 547 - 550



Rate this Article


Select Rating (Lowest: 1, Highest: 10)

5

Your Comments (Only high quality comments will be accepted.)

Characters: 0

Your Full Name:


Your Valid Email Address:


Verification Code will appear in 2 Seconds ... Wait

Top